To explore the mechanism by which MYC overexpression in cancer cells correlates with proscillaridin A sensitivity, we compared its effects between MYC driven leukemic cells (MOLT-4 and NALM-6) and low expressing MYC cancers driven by KRAS mutations (SW48 colon and A549 lung cancer cells). This evidence concerns the gene KRAS and cancer.